BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Withdrawn before enrolling · Phase 2

Conditions studied: Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer

In brief

RATIONALE: BAY 56-3722 may stop the growth of cancer cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of BAY 56-3722 in treating patients who have recurrent, unresectable, or metastatic kidney cancer.

Key facts

Study ID

NCT00040989

Run by

Jonsson Comprehensive Cancer Center

People needed

0

Last updated by the study team

2013-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• University of Colorado Cancer Center — Denver, Colorado, United States
• Oncology-Hematology Group of South Florida — Miami, Florida, United States
• Emory University Hospital - Atlanta — Atlanta, Georgia, United States
• Veterans Affairs Medical Center - Atlanta (Decatur) — Decatur, Georgia, United States
• Dwight David Eisenhower Army Medical Center — Fort Gordon, Georgia, United States
• Loyola University Medical Center — Maywood, Illinois, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• Tulane University School of Medicine — New Orleans, Louisiana, United States
• Louisiana State University Health Sciences Center - Shreveport — Shreveport, Louisiana, United States
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States
• Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
• University of Nebraska Medical Center — Omaha, Nebraska, United States
• Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
• University of Rochester Medical Center — Rochester, New York, United States
• Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
• Oregon Cancer Institute — Portland, Oregon, United States
• University of Pennsylvania Cancer Center — Philadelphia, Pennsylvania, United States
• Cancer Centers of the Carolinas — Greenville, South Carolina, United States
• Simmons Cancer Center - Dallas — Dallas, Texas, United States
• Baylor College of Medicine — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.